Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
drugs
2
×
exome
life sciences
accelerator
airbnb
amazon web services (aws)
artificial intelligence (a.i.)
athelas
atomwise
benchling
bioinnovation capital
biolabs
biotech
biotechnology
boston
boston top stories
cancer
chemotherapy
coinbase
coworking
cruise
culture biosciences
daraprim
data analytics
deals
detroit blog main
detroit top stories
doordash
dropbox
drug development
drug pricing
entrepreneurship
epipen
epipens
excepgen
financing
funding
gene therapy
generic drugs
What
life
2
×
sciences
2
×
admits
ago
big
biotech
biotechs
classes
combinator
companies
driving
drug
dug
good
healthcare
history
improved
incubator
industry
innovation
innovations
investment
long
medical
outcomes
previously
pricing
proud
public
sizable
started
startup
tech
they’re
welcome
wide
years
Language
unset
Current search:
xconomy.com
×
sciences
×
life
×
drugs
×
" boston blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good